Checkpoint Capital L.P. Rapt Therapeutics, Inc. Transaction History
Checkpoint Capital L.P.
- $182 Billion
- Q1 2025
A detailed history of Checkpoint Capital L.P. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Checkpoint Capital L.P. holds 109,830 shares of RAPT stock, worth $105,436. This represents 0.07% of its overall portfolio holdings.
Number of Shares
109,830Holding current value
$105,436% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
134MCall Options Held
41.3KPut Options Held
100-
Medicxi Ventures Management (Jersey) LTD22.4MShares$21.5 Million7.04% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$12.6 Million0.5% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$12.6 Million3.85% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$12 Million8.35% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$11.3 Million0.24% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $28.5M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...